Zevra Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
17 Jul 24 | BuyUS$13,540 | R. Clifton | Individual | 2,000 | US$6.77 | |
16 Jul 24 | BuyUS$68,065 | Thomas Anderson | Individual | 10,000 | US$6.81 | |
12 Jul 24 | BuyUS$58,661 | John Bode | Individual | 10,000 | US$5.87 |
Insider Trading Volume
Insider Buying: ZVRA insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 20,858 | 0.0396% |
Individual Insiders | 3,302,272 | 6.28% |
Institutions | 16,232,865 | 30.9% |
General Public | 33,061,794 | 62.8% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 55%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,021,660 | US$23.5m | 0% | no data | |||
2,697,052 | US$21.0m | 12.5% | no data | |||
2,419,435 | US$18.8m | -1.38% | 1.56% | |||
1,833,415 | US$14.3m | 7.59% | no data | |||
1,162,416 | US$9.1m | 240% | 3.32% | |||
1,147,583 | US$8.9m | 13.7% | 0.08% | |||
914,264 | US$7.1m | 16.2% | no data | |||
800,000 | US$6.2m | 0% | 0.55% | |||
719,859 | US$5.6m | 5.37% | no data | |||
458,300 | US$3.6m | 6.53% | 1.69% | |||
432,824 | US$3.4m | -34.4% | 0.01% | |||
297,947 | US$2.3m | 11.9% | 0.81% | |||
293,300 | US$2.3m | -1.27% | no data | |||
253,700 | US$2.0m | 0% | 0.01% | |||
220,499 | US$1.7m | 10.7% | no data | |||
181,673 | US$1.4m | 0% | 0.58% | |||
149,532 | US$1.2m | 5.42% | 0.11% | |||
142,548 | US$1.1m | 0% | no data | |||
138,504 | US$1.1m | 56.3% | no data | |||
129,730 | US$1.0m | 0% | no data | |||
112,800 | US$878.7k | -27.4% | no data | |||
110,318 | US$859.4k | 20.7% | no data | |||
106,000 | US$825.7k | 0% | no data | |||
106,000 | US$825.7k | 0% | 0.98% | |||
105,238 | US$819.8k | 32,300% | no data |